StockSelector.com
  Research, Select, & Monitor Sunday, May 26, 2019 7:34:23 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Viking Therapeutics, Inc.$8.54$.202.40%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Viking Therapeutics, Inc. has an overall rank of 294 out of 6809 stocks based on 11 positive rankings and 3 negative rankings.

Positive Rankings
Debt-to-Equity
Viking Therapeutics rank is 28
Target Prices
The average analysts' target price is $20.50 for Viking Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Viking Therapeutics is ranked 63.
Beat Whisper
According to EarningsWhispers.com, Viking Therapeutics beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
Beat Whisper
According to EarningsWhispers.com, Viking Therapeutics beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Viking Therapeutics is ranked 635.
Low vPut/Call
Viking Therapeutics has a low Put/Call ratio of 0.40 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Viking Therapeutics is ranked 685.
10 Day Gain
Viking Therapeutics rank is 843
Up EPS Surprise
Viking Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Low Put/Call
Viking Therapeutics has a low Put/Call ratio of 0.38 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Viking Therapeutics is ranked 919.
Up EPS Surprise
Viking Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
90 Day Gain
Viking Therapeutics rank is 2415
Negative Rankings
Negative ROA
Viking Therapeutics rank is 1248
Negative ROE
Viking Therapeutics rank is 1259
Price-to-Book
Viking Therapeutics rank is 2063







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.